C19Early.com Review: Early Treatment of COVID-19
This
review article
explores a superbly designed, highly navigable website that has continuously
updated the evidence-based research on early COVID-19 treatments since June
2020. The website is so exhaustively comprehensive that it could be considered a
journal in itself, produced by a team of competent, committed editors.
Although this singular resource has been developed and posted anonymously, one observer commented on Reddit, “It doesn’t really matter who built it, IMO. All studies are referenced/linked.”
The project has kept up with the recent highly encouraging work on many treatments for COVID-19.
Each of these treatment links can be opened to reveal a gold mine of further information.
The editors also offer an inclusion statement and an invitation to participate:
"Please send us corrections, updates, or comments.”
DISCLAIMER: The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site.
The Website Itself: The Home Page is at c19early.com
The studies for COVID’s readily-available, low-cost, and evidence-based early
treatments are divided into sections: Ivermectin, Proxalutamide, Budesonide, Vitamin D, Quercetin, Hydroxychloroquine, Vitamin C, Zinc and many more.
A comprehensive database and global list of COVID-19 treatment studies and outcomes, divided
into early treatment and late treatment results, and complete with
links and abstracts, is available at this site.
The project has kept up with the recent highly encouraging work on many treatments for COVID-19.
Each of these treatment links can be opened to reveal a gold mine of further information.
The editors also offer an inclusion statement and an invitation to participate:
"Please send us corrections, updates, or comments.”
Treatment (Alphabetical) Index and Directory
A
- Aspirin
- Artemisinin (Wormwood)
- Ashwagandha
- Anti-Coagulant
- Anti-Inflammatory
- Anti-Viral
- Azithromycin (Zithromax)
- Vitamin A
- Anakinra (for Cytokine Storm)
- abacavir
- acarbose
- adamumab
- adefovir
- Aframomum melegueta
- Afzelin
- amantadine
- amiodarone
- amitriptyline
- amlodipine
- amodiaquine
- amprenavir
- Amygdalin
- Andrographolide
- Anhydrosafflor yellow B
- Anisodamine apalutamide
- Apigenin
- apixaban
- APN01
- aprotinin
- arbidol
- ARD-61
- Arq Ajīb
- ASC09
- Ashwagandha
- Astragaloside IV
- atazanavir
- atorvastatin
- atovaquone
- Atractylenolide III
- avdoralimab
- AZD7442
- Azelastine
- azvudine
B
C
- Curcumin and Turmeric
- Casirivimab/imdevimab (REGEN-COV® in the U.S. and Ronapreve™ in the European Union (EU) and other countries)
- Colchicine
- Convalescent plasma
- Cetirizine (Zyrtec)
- Cetylpyridinum Chloride (CPC)
D
F
- FLCCC Protocols
- Fluvoxamine (Luvox)
- Fluoxetine (Prozac)
- Favipiravir
- Famotidine
- Fucoidan
G
H
I
- Ivermectin
- Iota Carrageenan
- I-MASK+ Protocol (Prevention and Early Treatment)
- I-MASS Protocol (Prevention and Early Treatment)
- I-Recover Protocol (Long COVID or Long Haulers)
L
M
- Melatonin
- MATH+ Protocol
- Methyl-Prednisolone
- Multivitamin
- Molecular Hydrogen
- Mouthwash
- Molnupiravir
- Metformin
- McCullough Protocol
N
- NAC and Glutathione
- Nasal Sprays
- Niatonin Protocol
- Nigella Sativa (Black Seed Oil)
- NSAIDs (Non Steroidal Anti Inflammatory Drugs)
- Nitazonide
O
P
- Paxlovid
- Probiotics
- Povidone Iodine
- Proxalutamide (Androgen Receptor Antagonist)
- Peter McCullough Protocol
- Pomegranate
Q
R
- Richard Bartlett Protocol (inhaled budesonide)
- Remdesivir
- Resveratrol
S
- Sanotize (Nasal Spray)
- Selenium
- SSRI (Selective Serotonin Reuptake Inhibitor)
- Sotrovimab (Xevudy)
- Saline (Nasal hygiene)
V
X
- Xylitol (Xlear)
Z
Related:
Comments